During the last 10 years, the United States FDA has approved only a few new treatments for diabetic foot ulcer (DFU). Amarex’s Kazem Kazempour, PhD, believes careful study design is required to demonstrate efficacy of new wound healing treatments. In this video, Kazempour explains the disconnect between the FDA’s definition of wound healing and the reality of DFUs … watch